When the levels of CaMkII and AMPK are reduced at the onset of neurodegenerative disease, the consequent reduced ability to express PGC-1α, FNDC5, BDNF, NGF, and GDNF could lead to cognitive dysfunction and deteriorating physical fitness [39]. The gene discussed is BDNF; the disease is neurodegenerative disease.